Ashvattha Therapeutics to Present Preclinical Data at the CMSC and SNMMI Annual Meetings tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Enrollment in PNT2002 s SPLASH trial is complete and topline data is expected in the fourth quarter of 2023 Next-generation actinium-225 PSMA program PNT2001 phase 1 trial design released; first. -Today at 07:31 am- MarketScreener
PSMA PET Imaging Enhances Prognosis Accuracy in Prostate Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.